An interventional study of TAPB and QIPB in Peripheral Nerve Block, Pain Management and Hernia, Inguinal, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 77 studies in Hernia, Inguinal with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Hernia, Inguinal · Turkey.
Among the 77 studies in Hernia, Inguinal with a site in Turkey, this one is the 38th largest by planned enrollment of the 60 interventional ones that give a count, is one of 9 that started in 2026, is one of 52 with no phase, reaches primary completion later than 8 of the 13 other live ones, and was the 67th registered.
545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.
Browse Hernia, Inguinal studies →12 of the 77 studies in Hernia, Inguinal with a site in Turkey are open now. Recruiting first, the newest first:
Hitit University · Sites in Turkey
Medipol University · Sites in Turkey
Ages 18–75
Haseki Training and Research Hospital · Sites in Turkey
Ages 18+
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–75
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Sites in Turkey
Ages 1–10
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
77 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 80 across the 60 interventional studies, 63 across the 17 observational. Of the 53 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 77 has an industry lead sponsor. The 10 most frequent:
Ankara Etlik City Hospital is the lead sponsor of 180 studies on the registry; 77 are open to participants now.
Ankara Etlik City Hospital has 1 study filed under Hernia, Inguinal — fewer than ten, so there is no comparison to draw.
3 of the studies in Hernia, Inguinal with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07612839Hakan EmirkadıIntravenous Lidocaine for Postoperative Fatigue After Laparoscopic TAPP Inguinal Hernia Repair | 2026-12-31 |
| NCT07891845Hitit UniversityComparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair | 2027-01-01 |
| NCT07604259Medipol UniversityComparison of QLB and TFP Block for Postoperative Analgesia in Laparoscopic Inguinal Hernia | 2027-04-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 77 studies in Hernia, Inguinal with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide. Despite being classified as a minor surgical intervention, moderate to severe postoperative pain is reported in approximately 60% of patients. In a subset of these patients, acute postoperative pain may persist and evolve into chronic post-surgical inguinal pain, significantly affecting quality of life.
In recent years, beyond the use of systemic intravenous analgesics, ultrasound-guided fascial plane blocks have been increasingly incorporated into multimodal analgesia protocols with the aim of reducing postoperative opioid consumption and improving pain control. However, the current literature does not provide definitive evidence regarding the superiority of one block technique over another in this surgical population.
The primary objective of the present study is to compare the analgesic efficacy of the Quadro-iliac Plane Block (QIPB) and the transversus abdominis plane block (TAPB) in patients undergoing inguinal hernia repair.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After the patients were placed under observation, positioned in the supine position, and appropriate area sterilization was performed, TAPB was administered to the patients with 30 ml of 0.25% bupivacaine under ultrasound guidance.
Procedure: TAPB
After the patients were placed under observation, positioned in the lateral decubitus position, and appropriate area sterilization was performed, QIPB was administered to the patients with 30 ml of 0.25% bupivacaine under ultrasound guidance.
Procedure: QIPB
Patients will undergo TAPB procedure using 30 ml of 0.25% bupivacaine under ultrasound guidance.
Patients will undergo QIPB procedure using 30 ml of 0.25% bupivacaine under ultrasound guidance.
Pain Score
Pain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest and when coughing. Pain assessment will be made at 0, 1, 6, 12, 18, and 24 hours after surgery.
Time frame: Up to 24 hours
Patient Satisfaction
Quality of recovery-15 (QoR-15) score was used as the satisfaction score. The patient-reported Turkish QoR-15 score includes 15 questions that evaluate the patient's postoperative recovery. The QoR-15 score is grouped under two groups, A and B. A high QoR-15 score, a score between 0 (poor) and 10 (excellent) for each item, and a total score of 150 indicate better quality of recovery.
Time frame: 24th hour
Started Jun 2026 (actual). Primary completion is estimated for Oct 2026, 4 months after the start.
Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 4 months is below that.
Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.